Australia markets closed

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
82.17-9.03 (-9.90%)
At close: 04:00PM EDT
82.20 +0.03 (+0.04%)
After hours: 07:46PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts16162121
Avg. Estimate0.380.451.662.94
Low estimate0.230.240.421.26
High estimate0.670.722.784.91
Year ago EPS0.290.210.871.66
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts23232827
Avg. Estimate668.85M693.33M2.76B3.15B
Low estimate651.8M674M2.61B2.82B
High estimate692.08M725.69M2.9B3.76B
Year ago salesN/A608.68M2.42B2.76B
Sales growth (year/est)N/A13.90%14.00%14.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.230.230.230.34
Actual EPS0.290.210.110.46
Difference0.06-0.02-0.120.12
Surprise %26.10%-8.70%-52.20%35.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.380.451.662.94
7 days ago0.370.431.62.71
30 days ago0.370.431.652.79
60 days ago0.470.52.063.23
90 days ago0.420.452.063.24
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1235
Up last 30 days3365
Down last 7 daysN/AN/AN/AN/A
Down last 30 days3122
Growth estimatesBMRNIndustrySector(s)S&P 500
Current qtr.31.00%N/AN/AN/A
Next qtr.114.30%N/AN/AN/A
Current year90.80%N/AN/AN/A
Next year77.10%N/AN/AN/A
Next 5 years (per annum)43.00%N/AN/AN/A
Past 5 years (per annum)-6.40%N/AN/AN/A